Cibus Expands Intellectual Property Coverage for Plant Gene Editing and Traits as Development Moves Closer to Commercialization
SAN DIEGO, Jan. 17, 2024 - Cibus, Inc. (NASDAQ: CBUS), a prominent agricultural technology company specializing in the development and licensing of plant traits to seed companies, has recently announced significant advancements in its intellectual property (IP) coverage for plant gene editing and traits. Over the past two quarters, the company has successfully obtained additional patents for 10 plant trait and editing families, consolidating its position as a leader in the field.
The expansion of Cibus’ IP coverage marks a major milestone for the company and sets the stage for further innovation and market growth. The patents obtained include a broad range of plant traits and editing techniques, catering to the diverse needs of farmers and seed companies worldwide.
One particular breakthrough that Cibus has achieved is the successful gene edits in Canola associated with the company’s third mode of action for its White Mold (Sclerotinia) Resistance Trait Program. This significant achievement demonstrates Cibus’ commitment to developing next-generation gene edits that enhance crop resilience and productivity.
The White Mold (Sclerotinia) Resistance Trait Program aims to combat a devastating fungal pathogen that affects a wide range of crops, including Canola. By introducing targeted genetic edits, Cibus aims to provide farmers with improved cultivars that are more resistant to White Mold, reducing the reliance on chemical pesticides and enabling sustainable agriculture.
Cibus has been actively engaged in field trials to evaluate the performance and efficacy of its developed traits. The 2023 Field Trial Results have been promising, bringing developed traits even closer to commercialization. The company’s dedication to rigorous testing and evaluation ensures that its traits meet the highest standards of quality, reliability, and safety.
Moving forward, Cibus plans to leverage its expanded IP coverage to accelerate the commercialization of its developed traits. The company aims to collaborate with seed companies globally, offering licenses for its cutting-edge gene editing technologies and innovative plant traits. This collaborative approach will allow Cibus to bring its transformative solutions to a wider range of crops and geographies, making a significant impact on global agriculture.
With the expansion of its intellectual property coverage and promising field trial results, Cibus is well-positioned to establish itself as a key player in plant gene editing and traits. By providing farmers with improved crop varieties, the company aims to contribute to food security, sustainability, and resilience in the face of climate change and other agricultural challenges.
Comments